arena pharmaceuticals inc
(ARNA:Consolidated Issue Listed on Nasdaq Glbl Slct Mrkt)
Executive Profile*
Phillip M. SchneiderDirector and Chairman of Audit Committee, Arena Pharmaceuticals, Inc. |
| Age | Total Calculated Compensation | This person is connected to 8 board members in 1 different organizations across 5 different industries. See Board Relationships |
| 55 | $347,139 |
Background*
Mr. Phillip M. Schneider served as the Chief Financial Officer of Biogen Idec Inc. (alternate name is IDEC Pharmaceuticals Corporation). During his 15-year tenure at IDEC, Mr. Schneider served as a Senior Vice President and Chief Financial Officer and played an integral role in its growth. Prior to his association with IDEC, Mr. Schneider held various management positions at Syntex Pharmaceuticals Corporation and previously worked with KPMG, LLP. Mr. Schneider has been ...
Corporate Headquarters*6154 Nancy Ridge DriveSan Diego, California 92121 United States Phone: 858-453-7200 Fax: 858-453-7210 Board Members Memberships*Former Director 2002-2012 Former Director, Chairman of Audit Committee and Member of Compensation Committee 2003-2007 Former Director and Chairman of Audit Committee 2003-N/A Former Director and Member of Audit Committee 2007-Present Director and Chairman of Audit Committee
Education*MBA University of Southern California BS University of California, Davis
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*
|
| Recently Viewed | |||
| ARNA:US | $7.92 USD | -0.07 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| James A. Bianco M.D. | Principal Founder, Chief Executive Officer, President and Executive Director Cell Therapeutics, Inc. | $1.2M |
| Leland F. Wilson | Chief Executive Officer and Director VIVUS Inc. | $738.0K |
| Andrew Philip Witty | Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee GlaxoSmithKline plc | 1.9M GBP |
| Severin Schwan | Chief Executive Officer and Director Roche Holding AG | SFr.6.5M |
| Zubair Ahmed | Managing Director, Director and Member of Whistle Blower Committee GlaxoSmithKline Consumer Healthcare Limited | 45.4M | Compensation as of Fiscal Year 2012. |
Post a JobJobs
Sponsored Financial Commentaries
Sponsored Links
To contact ARENA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
